HomeInsightsStock Comparison

Dr Lal Pathlabs Ltd vs Kms Medisurgi Ltd Stock Comparison

Dr Lal Pathlabs Ltd vs Kms Medisurgi Ltd Stock Comparison

Last Updated on: Jul 04, 2025

Key Highlights

  • The Latest Trading Price of Dr Lal Pathlabs Ltd is ₹ 2829 as of 04 Jul 11:39.
  • The P/E Ratio of Dr Lal Pathlabs Ltd changed from 51.7 on March 2020 to 42.5 on March 2025 . This represents a CAGR of -3.21% over 6 yearsThe P/E Ratio of KMS Medisurgi Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Dr Lal Pathlabs Ltd changed from ₹ 11679 crore on March 2020 to ₹ 20714 crore on March 2025 . This represents a CAGR of 10.02% over 6 yearsThe Market Cap of KMS Medisurgi Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Dr Lal Pathlabs Ltd for the Mar '25 is ₹ 628.4 crore as compare to the Dec '24 revenue of ₹ 621.8 crore. This represent the growth of 1.06% The revenue of KMS Medisurgi Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Dr Lal Pathlabs Ltd for the Mar '25 is ₹ 194.8 crore as compare to the Dec '24 ebitda of ₹ 179.1 crore. This represent the growth of 8.77% The ebitda of KMS Medisurgi Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Dr Lal Pathlabs Ltd changed from ₹ 83.6 crore to ₹ 155.5 crore over 8 quarters. This represents a CAGR of 36.38% The net profit of KMS Medisurgi Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Dr Lal Pathlabs Ltd changed from 49.24 % on March 2020 to 40.34 % on March 2025 . This represents a CAGR of -3.27% over 6 yearsThe Dividend Payout of KMS Medisurgi Ltd changed from 15 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dr Lal Pathlabs Ltd

  • Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi.
  • The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company.
  • The Company converted into a Public Limited Company and name of the Company was changed to Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015. Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres.
  • Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About KMS Medisurgi Ltd

  • KMS Medisurgi Limited was incorporated as 'KMS Medisurgi Private Limited' on March 25, 1999 at Mumbai.
  • The Company converted into a Public Limited Company and name was changed to 'KMS Medisurgi Limited' on June 15, 2016. The Company manufactures & undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive.
  • It is engaged in the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy Equipments, Blood Banking Equipments and other such Surgical Equipments in India. The Company was established in 1999 as surgical equipment company and since then it has been launching new concepts which helped the Indian Healthcare industry.

Dr Lal Pathlabs Ltd News Hub

News

Dr Lal Pathlabs strengthens its genomics capabilities with Illumina's NovaSeq' X Series

Dr Lal Pathlabs  (DLPL) has expanded its genomics capabilities by adding Illumina's NovaSe...

Read more

25 Jun 2025 13:53

News

Dr Lal Pathlabs strengthens its genomics capabilities with Illumina's NovaSeq' X Series

Dr Lal Pathlabs  (DLPL) has expanded its genomics capabilities by adding Illumina's NovaSe...

Read more

25 Jun 2025 13:53

News

Board of Dr. Lal PathLabs recommends final dividend

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held ...

Read more

25 Apr 2025 15:23

News

Dr. Lal PathLabs to convene AGM

Dr. Lal PathLabs announced that the Annual General Meeting(AGM) of the company will be hel...

Read more

25 Apr 2025 15:23

News

Dr. Lal PathLabs schedules board meeting

Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 25 April ...

Read more

19 Apr 2025 10:39

News

Dr Lal Pathlabs introduces highly specialized Amyloidosis test

Dr Lal Pathlabs has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spec...

Read more

15 Apr 2025 14:09

KMS Medisurgi Ltd News Hub

News

KMS Medisurgi to conduct board meeting

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 27 June 2025...

Read more

20 Jun 2025 13:39

News

KMS Medisurgi to table results

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 30 May 2025....

Read more

24 May 2025 13:48

News

KMS Medisurgi to hold board meeting

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

12 Nov 2024 14:12

News

Board of KMS Medisurgi recommends final dividend

KMS Medisurgi announced that the Board of Directors of the Company at its meeting held on ...

Read more

28 Aug 2024 17:43

News

KMS Medisurgi to hold AGM

KMS Medisurgi announced that the 26th Annual General Meeting (AGM) of the company will be ...

Read more

28 Aug 2024 17:43

News

KMS Medisurgi to consider Dividend

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 28 August 20...

Read more

20 Aug 2024 16:27

SWOT Analysis Of KMS Medisurgi Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Dr Lal Pathlabs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for KMS Medisurgi Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Lal Pathlabs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dr Lal Pathlabs Ltd and KMS Medisurgi Ltd

Which company has a larger market capitalization, Dr Lal Pathlabs Ltd or KMS Medisurgi Ltd?

Market cap of Dr Lal Pathlabs Ltd is 23,078 Cr while Market cap of KMS Medisurgi Ltd is 41 Cr

What are the key factors driving the stock performance of Dr Lal Pathlabs Ltd and KMS Medisurgi Ltd?

The stock performance of Dr Lal Pathlabs Ltd and KMS Medisurgi Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lal Pathlabs Ltd and KMS Medisurgi Ltd?

As of July 4, 2025, the Dr Lal Pathlabs Ltd stock price is INR ₹2754.75. On the other hand, KMS Medisurgi Ltd stock price is INR ₹126.9.

How do dividend payouts of Dr Lal Pathlabs Ltd and KMS Medisurgi Ltd compare?

To compare the dividend payouts of Dr Lal Pathlabs Ltd and KMS Medisurgi Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions